T

Teva Pharmaceutical Industries Limited
D

TEVA

17.120
USD
0.05
(0.29%)
Market Closed
Volume
221,706
EPS
2
Div Yield
-
P/E
-20
Market Cap
19,397,819,664
Related Instruments
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    748 USD
    M
    MNK
    -0.06490
    (-16.07%)
    0.33900 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    104.29 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    P
    PRGO
    -0.140
    (-0.52%)
    26.800 USD
    More
News

Title: Teva Pharmaceutical Industries Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.